Deficiency of the type I interferon receptor protects mice from experimental lupus. - Wikidata - wikimedia - TriplyDB

Deficiency of the type I interferon receptor protects mice from experimental lupus.

Deficiency of the type I interferon receptor protects mice from experimental lupus.

http://www.wikidata.org/entity/Q34016334

about

Role of type I interferons in the activation of autoreactive B cells A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses Constitutive type I interferon modulates homeostatic balance through tonic signaling Genetic complementation results in augmented autoantibody responses to lupus-associated antigens.High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Dendritic cells in systemic lupus erythematosus Interferons and their stimulated genes in the tumor microenvironment Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage Murine models of systemic lupus erythematosus Requirements for innate immune pathways in environmentally induced autoimmunity.The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.Toxicology of autoimmune diseases.Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Animal Models of Interferon Signature Positive Lupus.Toll-like receptors: potential targets for lupus treatment Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset Janus-like effects of type I interferon in autoimmune diseases.B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis Innate pathways to B-cell activation and tolerance.IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus Estrogen Receptor α Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.

P2860

Q26858821-4D09DF62-DC7A-4707-AD1A-1B437BCE0DBF Q28118033-B388E91D-DAF6-466C-9728-AA754AF07539 Q28260631-EFD2DFBD-2F76-4AB8-8646-2E105DEDD401 Q30434941-23CD795F-240A-43D6-BB12-4F4F915CB1FF Q33523155-4494760A-978E-4B42-9576-089F2529F2D1 Q33804141-CDA63EF4-D5B5-4B2C-82AC-B46316F8D1AF Q33806541-97A44A38-D524-46DB-90A7-367DD2480EE8 Q33941433-7E68662D-4C10-48C6-BD53-18F80F083F64 Q33988567-B1B4CFD1-CE2F-4F64-B9AB-24F22F00DCAF Q33992328-E40AA9CB-696E-49EA-B31E-24451D41CA10 Q34090517-677553FD-C122-493B-BC9B-9EB615691DA7 Q34187236-F37F7BF2-85EE-4DB6-B99B-18A929828F3B Q34230589-3863BECE-4AED-4CC7-8E7E-2F9439044968 Q34240254-652CE97F-1850-4EC7-B301-286F9794DBA9 Q34420821-C7127EA2-CEF4-4FB8-867C-95DA0474EB52 Q34443260-EB1F93B3-E9AB-4267-A561-44E29D536224 Q34591019-57407F40-8456-436E-BCD2-84ADD0EA99DA Q34655526-A5DA6CAD-4EF6-4CC4-9B10-B7B92452CCFB Q34779998-9246EB40-261E-40CE-95CF-36BAF5DF5629 Q34781487-D603A2D6-C0EA-458C-978A-D16E3641F1D2 Q34788943-94B846DB-85AC-4581-AE3D-EE48FC2239F4 Q34790990-DA24A59C-CBC0-4A90-ABD1-36E385470639 Q35152132-0B86874D-71F6-4D0F-8DFC-128234CC2A44 Q35685720-B117CBAF-2017-48CB-9C6E-010EFF7C4863 Q35686914-8A9DBE3F-C4AA-40A5-B3A2-49256D447A55 Q35848152-94E417C7-4190-4BE1-81B4-B74987A377CD Q35848476-0A42F7C2-2CD7-4407-8ADE-79BD911FE071 Q35936143-B41DF253-E514-40D0-AC71-CF5C074761C9 Q36054583-F5521B7C-4BBD-4B54-9990-9FA9BCE1EAE0 Q36059960-FAB6006F-B022-4555-A71E-467EA90D6C6B Q36091161-B2E4DC4D-3099-4577-A62D-A238E46783A0 Q36139902-412F2131-DCED-43F9-91C0-392DD6A644C0 Q36172913-3AF1F0AF-4DC3-416D-9496-DF647D9F75B9 Q36232213-0A2767C7-1F7B-4F55-9B5A-0EF26DAB138B Q36490737-C1144592-7BA4-4FD7-B9A8-8D63205DC2FD Q36494607-E3723B04-CEDF-4198-875F-11855AA7FC7F Q36549197-1D3CD948-77D3-400A-8C4B-59DCDB2E66EC Q36632390-B14852D6-5358-4DBA-8913-26739062751A Q36682785-55755874-FAA0-4B31-95F7-86393472D933 Q36712941-46E5EDB8-F8F2-4EB5-AD95-BA8D665A7FF0

P2860

Deficiency of the type I interferon receptor protects mice from experimental lupus.

http://www.wikidata.org/entity/Q34016334

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@ast

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@en

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@nl

type

label

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@ast

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@en

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@nl

prefLabel

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@ast

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@en

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@nl

P1433

Q34016334-2B544DE5-0BCB-4470-A58B-C54315FE4895

P1476

Q34016334-138A3E81-F672-4394-BAC5-BAE8E0D9FD3F

P2093

Q34016334-2C8A0335-E0E1-4CF6-98C4-72172AC16FD9

Q34016334-39347E60-418E-43AF-B55C-ABE6BBEBAA1B

Q34016334-6F1D4830-FC00-4BD3-B37B-6C3137EC3B83

Q34016334-9B33F9D3-A8FF-4239-869D-52017880B8DE

Q34016334-A116EE8E-ABDC-4C3B-94F1-3A8FF7F6C041

Q34016334-BFEECBC1-33E5-4823-95E2-CE7A8A253805

Q34016334-CB56475F-99C0-41FC-8BB7-03663971C4D7

Q34016334-D2FA6C00-5BDD-4FBC-BC0E-9F3328B4E04E

P2860

Q34016334-0900E64E-909B-4EB6-91FF-2FE21E1635DF

Q34016334-0AD7DD60-9779-490F-B816-56A1A49A600B

Q34016334-101AE55B-0F40-4B9D-8976-78634C857CE8

Q34016334-124BBF47-83FE-4808-90AC-EFE0E6B30BAE

Q34016334-1878859A-7598-468C-95DF-AFF6B4B9FBDB

Q34016334-1A0D3A59-5748-4CF9-B20F-E7CF98A34347

Q34016334-1D29A26C-8BF2-41C0-BDBA-5D42DFBEA63A

Q34016334-1E58A6B8-714D-4920-A8DB-91968A4CB662

Q34016334-1F0112C2-69FF-404C-BB73-08740751659D

Q34016334-2A7B8738-FB63-4DE9-A9E9-F6836E39E272

P304

Q34016334-19B7EA45-4C0D-4181-BD44-3BE8DCA09E65

P31

Q34016334-2C44B3EA-4BA5-42A6-9CD2-58534F25627C

P356

Q34016334-FFB99D1A-ACB5-4EB2-A695-696C60AF5B86

P433

Q34016334-371809C4-448E-48CD-B33A-B4CC28B8104B

P478

Q34016334-67FCD07E-27B5-4EC8-93DB-BB4255E9AD31

P577

Q34016334-6C56357C-F2B7-4B82-B6DE-98754F278399

P5875

Q34016334-DFFE9F24-F23C-4B51-881A-C16F8D4EDD8A

P698

Q34016334-E3E5C3B8-5AD0-4744-B056-66808495713D

P932

Q34016334-9F30CC9F-FFD8-4C3D-B478-BC688D30A037

P356

P1433

Arthritis & Rheumatology

P1476

Deficiency of the type I interferon receptor protects mice from experimental lupus.

@en

P2093

Dina C Nacionales

http://www.w3.org/2001/XMLSchema#string

Eric Sobel

http://www.w3.org/2001/XMLSchema#string

Jason S Weinstein

http://www.w3.org/2001/XMLSchema#string

Kindra M Kelly-Scumpia

http://www.w3.org/2001/XMLSchema#string

Minoru Satoh

http://www.w3.org/2001/XMLSchema#string

Pui Y Lee

http://www.w3.org/2001/XMLSchema#string

Robert Lyons

http://www.w3.org/2001/XMLSchema#string

Westley H Reeves

http://www.w3.org/2001/XMLSchema#string

P2860

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

Functional role of type I and type II interferons in antiviral defense

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

The role of APRIL and BAFF in lymphocyte activation

The 1982 revised criteria for the classification of systemic lupus erythematosus

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

P304

3770-3783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.23023

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5877237

http://www.w3.org/2001/XMLSchema#string

P698

17968932

http://www.w3.org/2001/XMLSchema#string

P932

2909118

http://www.w3.org/2001/XMLSchema#string